Perturbed hepatic function in an ecstasy consumer;Perturbation du bilan hépatique chez un consommateur d'ecstasy

Presse Medicale

Volumn 33, Issue 18 SUPPL., 2004, Pages 18-20

  Aknine, Xavier ^a  

^a Centre Hospitalier Robert Ballanger CHRB   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; CANNABIS; GAMMA GLUTAMYLTRANSFERASE; AMINOTRANSFERASE; PSYCHOTROPIC AGENT;

ADULT; ALLERGY; ANEMIA; APOPTOSIS; CASE REPORT; CHOLESTASIS; DRUG DEPENDENCE; ECHOGRAPHY; HUMAN; HYPERSENSITIVITY; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER TOXICITY; MALE; MALIGNANT HYPERTHERMIA; REVIEW; VIRUS HEPATITIS; AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; HEPATITIS;

EID: 7944221777     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(04)72377-5     Document Type: Article

References (13)

1. Becker J, Neis P, Rohrich J, Zorntlein S. A fatal paramethoxymethamphetamine intoxication. Leg Med 2003; 5 Suppl: S138-41.
2. Carrion JA, Escorsell A, Nogue S, Mas A. Ecstasy-induced fulminant hepatic failure and emergency liver transplantation. Med Clin 2003; 12: 118-19.
3. Roques V, Perney P, Beaufort P et al. Hépatite aiguë ȧ l'ecstasy. Presse Med 1998; 27; 468-70.
4. Carvalho M et al. Effect of ecstasy on body temperature and liver antioxydant status in mice: influence of ambient temperature. Archives of Toxicology 2002; 76: 166-72.
5. Johnson EA et al. d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity. Brain Research 2002; 933: 150-63.
6. Andreu V et al. Ecstasy: a common cause of severe acute hepatotoxicity. Hepatotogy 1998; 29: 394-7.
7. Nunez O et al. Variability of the clinical expression of Ecstasy-induced hepatotoxicity. Gastroenterologia y Hepatologia 2002; 25: 497-500.
8. Montiel-Duarte C et al. Ecstasy induces apoptosis of cultured rat liver cells, Biochimica et Biophysica Acta 2002; 1588: 26-32.
9. Ravina P, Quiroga JM, Ravina T. Hyperkaliema in fatal MDMA (ecstasy) toxicity. Int J Cardiol 2004; 93: 307-8.
10. Lange-Brock N et al. Acute liver failure following the use of ecstasy (MDMA). Z Gastroenterol 2002; 40: 581-6.
11. Maurer HH et al. Chemistry, pharmacology, toxicology and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine and pyrrolidinophenone types: a synopsis. The Drug Monit 2004; 26: 127-31.
12. Carvalho M et al. Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Arch Toxiol 2004; 78: 16-24.
13. Simon L et al. Pharmacologie et toxicologie cliniques de l'ecstasy. L'Information Psychiatrique 2003; 3: 233-42.